David P. Schenkein - Insider Trading & Ownership

Location
C/O Bluebird Bio, Inc., 840 Memorial Drive, Cambridge, MA
Summary
The estimated net worth of David P. Schenkein is at least $11.2M dollars as of August 5, 2025. David P. Schenkein is the Director of AGIOS PHARMACEUTICALS, INC. and owns shares of AGIOS PHARMACEUTICALS, INC. (AGIO) stock worth about $10.1M. David P. Schenkein is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $764K. David P. Schenkein is the Director of REGENERON PHARMACEUTICALS, INC. and owns shares of REGENERON PHARMACEUTICALS, INC. (REGN) stock worth about $317K.
Signature
/s/ Ryan Brown, attorney-in-fact
All Insider Reports
All Insider Reports

Ownership of David P. Schenkein

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AGIO AGIOS PHARMACEUTICALS, INC. Director $10.1M Jun 20, 2024
DNLI Denali Therapeutics Inc. Director $764K -$1.93M -71.7% Jun 3, 2025
REGN REGENERON PHARMACEUTICALS, INC. Director $317K Jan 2, 2025
PRME Prime Medicine, Inc. Director Aug 1, 2025

Insider Transactions Reported by David P. Schenkein:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.